Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.56 - $2147.95 $8,986 - $34.5 Million
16,047 New
16,047 $9,000
Q2 2022

Aug 10, 2022

SELL
$0.48 - $1.12 $2,362 - $5,512
-4,922 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.85 - $1.27 $7,444 - $11,122
-8,758 Reduced 64.02%
4,922 $5,000
Q4 2021

Feb 14, 2022

BUY
$1.13 - $2.26 $14,413 - $28,826
12,755 Added 1378.92%
13,680 $16,000
Q3 2021

Nov 15, 2021

SELL
$2.12 - $4.6 $2,060 - $4,471
-972 Reduced 51.24%
925 $2,000
Q2 2021

Aug 13, 2021

BUY
$3.53 - $5.98 $6,696 - $11,344
1,897 New
1,897 $8,000

About Nuwellis, Inc.


  • Ticker NUWE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,531,600
  • Market Cap $55.8M
  • Description
  • Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex ...
More about NUWE
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.